Natera, Inc.

NasdaqGS:NTRA Voorraadrapport

Marktkapitalisatie: US$16.2b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Natera Beheer

Beheer criteriumcontroles 3/4

De CEO Natera's is Steve Chapman, benoemd in Jan2019, heeft een ambtstermijn van 5.75 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 12.73M, bestaande uit 5.9% salaris en 94.1% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.024% van de aandelen van het bedrijf, ter waarde $ 3.80M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.8 jaar en 7.6 jaar.

Belangrijke informatie

Steve Chapman

Algemeen directeur

US$12.7m

Totale compensatie

Percentage CEO-salaris5.9%
Dienstverband CEO5.8yrs
Eigendom CEO0.02%
Management gemiddelde ambtstermijn5.8yrs
Gemiddelde ambtstermijn bestuur7.6yrs

Recente managementupdates

Recent updates

Natera, Inc.'s (NASDAQ:NTRA) Intrinsic Value Is Potentially 20% Below Its Share Price

Sep 18
Natera, Inc.'s (NASDAQ:NTRA) Intrinsic Value Is Potentially 20% Below Its Share Price

Does Natera (NASDAQ:NTRA) Have A Healthy Balance Sheet?

Jul 05
Does Natera (NASDAQ:NTRA) Have A Healthy Balance Sheet?

Natera: Overdue For A Breather

Jun 03

Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$119

May 12
Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$119

Is There An Opportunity With Natera, Inc.'s (NASDAQ:NTRA) 41% Undervaluation?

Mar 30
Is There An Opportunity With Natera, Inc.'s (NASDAQ:NTRA) 41% Undervaluation?

Natera: Capitalizing On The Positive Momentum Of Personalized Medicine

Mar 22

Is Natera (NASDAQ:NTRA) A Risky Investment?

Mar 03
Is Natera (NASDAQ:NTRA) A Risky Investment?

Estimating The Fair Value Of Natera, Inc. (NASDAQ:NTRA)

Dec 11
Estimating The Fair Value Of Natera, Inc. (NASDAQ:NTRA)

Is Natera (NASDAQ:NTRA) A Risky Investment?

Nov 10
Is Natera (NASDAQ:NTRA) A Risky Investment?

Natera, Inc. (NASDAQ:NTRA) Shares Could Be 46% Below Their Intrinsic Value Estimate

Aug 07
Natera, Inc. (NASDAQ:NTRA) Shares Could Be 46% Below Their Intrinsic Value Estimate

Health Check: How Prudently Does Natera (NASDAQ:NTRA) Use Debt?

May 16
Health Check: How Prudently Does Natera (NASDAQ:NTRA) Use Debt?

Natera, Inc.'s (NASDAQ:NTRA) Low P/S No Reason For Excitement

Apr 18
Natera, Inc.'s (NASDAQ:NTRA) Low P/S No Reason For Excitement

Analyse CEO-vergoeding

Hoe is Steve Chapman's beloning veranderd ten opzichte van Natera's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$292m

Mar 31 2024n/an/a

-US$365m

Dec 31 2023US$13mUS$751k

-US$435m

Sep 30 2023n/an/a

-US$499m

Jun 30 2023n/an/a

-US$512m

Mar 31 2023n/an/a

-US$546m

Dec 31 2022US$8mUS$610k

-US$548m

Sep 30 2022n/an/a

-US$546m

Jun 30 2022n/an/a

-US$576m

Mar 31 2022n/an/a

-US$546m

Dec 31 2021US$23mUS$526k

-US$472m

Sep 30 2021n/an/a

-US$408m

Jun 30 2021n/an/a

-US$315m

Mar 31 2021n/an/a

-US$258m

Dec 31 2020US$8mUS$487k

-US$230m

Sep 30 2020n/an/a

-US$189m

Jun 30 2020n/an/a

-US$153m

Mar 31 2020n/an/a

-US$126m

Dec 31 2019US$6mUS$451k

-US$125m

Sep 30 2019n/an/a

-US$121m

Jun 30 2019n/an/a

-US$128m

Mar 31 2019n/an/a

-US$129m

Dec 31 2018US$1mUS$373k

-US$128m

Sep 30 2018n/an/a

-US$144m

Jun 30 2018n/an/a

-US$142m

Mar 31 2018n/an/a

-US$137m

Dec 31 2017US$2mUS$369k

-US$138m

Compensatie versus markt: De totale vergoeding ($USD 12.73M ) Steve } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 13.04M ).

Compensatie versus inkomsten: De vergoeding van Steve is gestegen terwijl het bedrijf verliesgevend is.

CEO

Steve Chapman (45 yo)

5.8yrs

Tenure

US$12,727,887

Compensatie

Mr. Steven Leonard Chapman, also known as Steve, has been Chief Executive Officer and Director at Natera, Inc. since January 02, 2019. He served as President at Natera, Inc. since January 02, 2019. Mr. Cha...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Matthew Rabinowitz
Co-Founder & Executive Chairman19.8yrsUS$8.97m1.91%
$ 309.4m
Steven Chapman
CEO & Director5.8yrsUS$12.73m0.024%
$ 3.9m
Michael Brophy
Chief Financial Officer7.7yrsUS$5.07m0.0077%
$ 1.3m
Daniel Rabinowitz
Secretary & Chief Legal Officerno dataUS$3.33m0.13%
$ 20.9m
John Fesko
President & Chief Business Officer1.1yrsgeen gegevens0.042%
$ 6.8m
Jonathan Sheena
Co-Founder & Directorno dataUS$657.99k0.31%
$ 51.0m
Olesya Anisimova
Chief Accounting Officer2.6yrsgeen gegevensgeen gegevens
Rishi Kacker
Chief Technology Officerno datageen gegevensgeen gegevens
Eric Evans
Chief Scientific Officer4.7yrsgeen gegevensgeen gegevens
Jerry Diffley
Chief Compliance & Privacy Officer7.2yrsgeen gegevensgeen gegevens
Phil Grinnell
Vice President of Sales8.6yrsgeen gegevensgeen gegevens
Solomon Moshkevich
President of Clinical Diagnosticsno datageen gegevens0.017%
$ 2.8m

5.8yrs

Gemiddelde duur

45yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van NTRA is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.8 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Matthew Rabinowitz
Co-Founder & Executive Chairman19.8yrsUS$8.97m1.91%
$ 309.4m
Steven Chapman
CEO & Director5.8yrsUS$12.73m0.024%
$ 3.9m
Jonathan Sheena
Co-Founder & Director17.8yrsUS$657.99k0.31%
$ 51.0m
James Healy
Independent Director9.9yrsUS$329.64k0.035%
$ 5.6m
Herman Rosenman
Independent Director7.7yrsUS$339.16k0.050%
$ 8.2m
Roelof Botha
Lead Independent Director17.8yrsUS$350.98k1.06%
$ 172.1m
Gail Marcus
Independent Director7.6yrsUS$337.22k0.015%
$ 2.4m
Rowan Chapman
Independent Director5.2yrsUS$338.72k0.0037%
$ 608.1k
Roy Baynes
Independent Director6.3yrsUS$317.73k0.010%
$ 1.7m
Ruth Williams-Brinkley
Independent Director1.6yrsUS$433.44kgeen gegevens

7.6yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van NTRA wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.6 jaar).